📰 Joseph Damasio News
Joseph Damasio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Joseph Damasio. Real-time updates on events, politics, business and more.
April 2, 2024
02.04.2024 - Established a Research Collaboration with the McGowan Institute for Regenerative Medicine at the University of Pittsburgh to Study the Repair and Regeneration of the Colon following ColectomyEstablished a Collaboration with Hugh Taylor, MD, chair of ...
November 9, 2023
HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“HRGN” or the “Company”), a...
August 28, 2023
/PRNewswire/ -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) ("Harvard Apparatus Regenerative Technology" or the "Company"), a clinical-stage...
August 21, 2023
/PRNewswire/ -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) ("Harvard Apparatus Regenerative Technology" or the "Company"), a clinical-stage...
August 9, 2023
/PRNewswire/ -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) ("HRGN" or the "Company"), a clinical-stage biotechnology company developing the...
July 19, 2023
HOLLISTON - Biostage, Inc. , a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, including cancer, trauma and birth...
June 13, 2023
HOLLISTON, Mass., June 13, 2023 /PRNewswire/ -- Biostage, Inc. , a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases,... | June 13, 2023
June 13, 2023
/PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company developing the technology to regenerate...
March 2, 2023
/PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company developing regenerative-medicine treatments...
January 12, 2023
/PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company developing regenerative-medicine treatments...